Wolf Group Capital Advisors Johnson & Johnson Transaction History

Wolf Group Capital Advisors

$290 Million
Q1 2025

A detailed history of Wolf Group Capital Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Wolf Group Capital Advisors holds 15,766 shares of JNJ stock, worth $2.42 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

15,766

Previous 14,531 8.5%

Holding current value

$2.42 Million

Previous $2.1 Million 24.42%

% of portfolio

0.9%

Previous 0.91%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	BUY	$142.06 - $167.7 $175,444 - $207,109	1,235 Added 8.5%	15,766 $2.61 Million
Q3 2024 Oct 31, 2024	SELL	$145.48 - $167.38 $311,909 - $358,862	-2,144 Reduced 12.86%	14,531 $2.35 Million
Q2 2024 Jul 30, 2024	BUY	$144.38 - $157.78 $309,550 - $338,280	2,144 Added 14.75%	16,675 $2.44 Million
Q4 2023 Jan 22, 2024	BUY	$145.6 - $158.88 $30,430 - $33,205	209 Added 1.46%	14,531 $2.28 Million
Q3 2023 Oct 31, 2023	SELL	$155.75 - $174.48 $13,550 - $15,179	-87 Reduced 0.6%	14,322 $2.23 Million
Q2 2023 Jul 31, 2023	SELL	$154.35 - $166.11 $80,725 - $86,875	-523 Reduced 3.5%	14,409 $2.38 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $274,004 - $326,991	-1,814 Reduced 10.83%	14,932 $2.31 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $141,456 - $158,754	-883 Reduced 5.01%	16,746 $2.96 Million
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $1,129 - $1,256	-7 Reduced 0.04%	17,629 $2.88 Million
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $957,169 - $1.06 Million	-5,691 Reduced 24.4%	17,636 $3.13 Million
Q1 2022 Apr 20, 2022	SELL	$158.14 - $179.59 $8.78 Million - $9.97 Million	-55,504 Reduced 70.41%	23,327 $4.13 Million
Q4 2021 Jan 19, 2022	BUY	$155.93 - $173.01 $8.28 Million - $9.19 Million	53,101 Added 206.38%	78,831 $13.5 Million
Q3 2021 Oct 20, 2021	SELL	$161.5 - $179.47 $29,716 - $33,022	-184 Reduced 0.71%	25,730 $4.16 Million
Q2 2021 Jul 28, 2021	BUY	$159.48 - $171.07 $90,265 - $96,825	566 Added 2.23%	25,914 $4.27 Million
Q1 2021 Apr 19, 2021	BUY	$153.07 - $170.48 $84,647 - $94,275	553 Added 2.23%	25,348 $4.17 Million
Q4 2020 Jan 29, 2021	SELL	$137.11 - $157.38 $15,219 - $17,469	-111 Reduced 0.45%	24,795 $3.9 Million
Q3 2020 Oct 30, 2020	SELL	$140.38 - $153.83 $8,703 - $9,537	-62 Reduced 0.25%	24,906 $3.71 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $112,451 - $135,760	873 Added 3.62%	24,968 $3.51 Million
Q1 2020 Apr 16, 2020	BUY	$111.14 - $153.99 $26,229 - $36,341	236 Added 0.99%	24,095 $3.16 Million
Q4 2019 Jan 29, 2020	BUY	$127.5 - $146.44 $232,687 - $267,253	1,825 Added 8.28%	23,859 $3.48 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $105,876 - $118,544	834 Added 3.93%	22,034 $2.85 Million
Q2 2019 Jul 17, 2019	SELL	$131.15 - $144.24 $101,641 - $111,786	-775 Reduced 3.53%	21,200 $2.95 Million
Q1 2019 Apr 22, 2019	SELL	$125.72 - $139.79 $8,297 - $9,226	-66 Reduced 0.3%	21,975 $3.07 Million
Q4 2018 Jan 22, 2019	BUY	$122.84 - $147.84 $8,721 - $10,496	71 Added 0.32%	22,041 $2.84 Million
Q3 2018 Oct 23, 2018	SELL	$121.58 - $142.88 $21,154 - $24,861	-174 Reduced 0.79%	21,970 $3.04 Million
Q2 2018 Jul 12, 2018	BUY	$119.4 - $131.76 $301,843 - $333,089	2,528 Added 12.89%	22,144 $2.69 Million
Q1 2018 Apr 25, 2018	BUY	$125.1 - $148.14 $1.28 Million - $1.52 Million	10,235 Added 109.1%	19,616 $2.51 Million
Q4 2017 Feb 12, 2018	BUY	$131.22 - $143.62 $414,523 - $453,695	3,159 Added 50.77%	9,381 $1.31 Million
Q3 2017 Oct 23, 2017	SELL	$129.47 - $135.38 $85,838 - $89,756	-663 Reduced 9.63%	6,222 $847,000
Q2 2017 Aug 09, 2017	BUY	N/A	6,885	6,885 $911,000

Others Institutions Holding JNJ

# of Institutions

4,652

Shares Held

1.73B

Call Options Held

25M

Put Options Held

15.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $401B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Wolf Group Capital Advisors with notifications on news.

Account

Wolf Group Capital Advisors Johnson & Johnson Transaction History